Johnson WD - Search Results

1

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ.

McCormick DL, Horn TL, Johnson WD, Peng X, Lubet RA, Steele VE. McCormick DL, et al. Among authors: johnson wd. PLoS One. 2015 Oct 30;10(10):e0141849. doi: 10.1371/journal.pone.0141849. eCollection 2015. PLoS One. 2015. PMID: 26516762 Free PMC article.

2

Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.

McCormick DL, Phillips JM, Horn TL, Johnson WD, Steele VE, Lubet RA. McCormick DL, et al. Among authors: johnson wd. Cancer Prev Res (Phila). 2010 Jan;3(1):73-81. doi: 10.1158/1940-6207.CAPR-09-0151. Cancer Prev Res (Phila). 2010. PMID: 20051374 Free PMC article.

3

Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide.

Peng X, Li W, Johnson WD, Torres KE, McCormick DL. Peng X, et al. Among authors: johnson wd. PLoS One. 2015 Jan 30;10(1):e0116285. doi: 10.1371/journal.pone.0116285. eCollection 2015. PLoS One. 2015. PMID: 25635769 Free PMC article.

4

Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.

McCormick DL, Johnson WD, Kozub NM, Rao KV, Lubet RA, Steele VE, Bosland MC. McCormick DL, et al. Among authors: johnson wd. Carcinogenesis. 2007 Feb;28(2):398-403. doi: 10.1093/carcin/bgl141. Epub 2006 Sep 3. Carcinogenesis. 2007. PMID: 16952912

5

Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.

McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE. McCormick DL, et al. Among authors: johnson wd. Nutr Cancer. 2007;57(2):184-93. doi: 10.1080/01635580701277478. Nutr Cancer. 2007. PMID: 17571952

6

Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat.

McCormick DL, Johnson WD, Haryu TM, Bosland MC, Lubet RA, Steele VE. McCormick DL, et al. Among authors: johnson wd. Nutr Cancer. 2007;57(2):194-200. doi: 10.1080/01635580701277494. Nutr Cancer. 2007. PMID: 17571953

7

Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

McCormick DL, Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE. McCormick DL, et al. Among authors: johnson wd. Cancer Prev Res (Phila). 2010 Mar;3(3):381-92. doi: 10.1158/1940-6207.CAPR-09-0176. Epub 2010 Feb 9. Cancer Prev Res (Phila). 2010. PMID: 20145190 Free PMC article.

8

Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

Kapetanovic IM, Horn TL, Johnson WD, Cwik MJ, Detrisac CJ, McCormick DL. Kapetanovic IM, et al. Among authors: johnson wd. Int J Toxicol. 2010 Mar-Apr;29(2):157-64. doi: 10.1177/1091581809360070. Int J Toxicol. 2010. PMID: 20335511

9

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.

Kapetanovic IM, Muzzio M, McCormick DL, Thompson TN, Johnson WD, Horn TL, Mohammed A, Rao CV, Kopelovich L. Kapetanovic IM, et al. Among authors: johnson wd. Cancer Chemother Pharmacol. 2012 May;69(5):1301-6. doi: 10.1007/s00280-011-1811-9. Cancer Chemother Pharmacol. 2012. PMID: 22302406

10

Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.

McCormick DL, Rao KV, Johnson WD, Bowman-Gram TA, Steele VE, Lubet RA, Kellof GJ. McCormick DL, et al. Among authors: johnson wd. Cancer Res. 1996 Apr 15;56(8):1724-6. Cancer Res. 1996. PMID: 8620482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters